Healthcare Provider Guidance

COVID-19 Update for Healthcare every Tuesday at 11AM – Register here:

PPE & Supply Requests: Please see our PPE & Supply Request page.

Guidance documents for COVID-19

Healthcare Providers:

Infection Control:



At a glance:

HCP_PUI_testing_criteria Opens in new windowDownload the PDFHCP_infection_control_recommendations Opens in new windowDownload the PDF

For patients who meet COVID-19 Persons Under Investigation (PUI) criteria:

1) Healthcare personnel entering the room should use droplet, contact, and standard precautions, plus eye protection (e.g., goggles or a face shield) and patients can be evaluated in a private room with the door closed (unless performing aerosol-generating procedures, which should be performed in an AIIR);

2) Immediately notify your healthcare facility’s infection control personnel;

3) Immediately notify Maricopa County Department of Public Health:

  • Monday–Friday 8AM–5PM — call (602) 506-6767 and ask for a Surveillance Nurse or;
  • After 5PM and on weekends — call (602) 747-7111 and ask for the Provider On-Call.

4) Collect specimens for testing for COVID-19, which include:

  • Lower respiratory specimen (e.g., sputum, BAL, tracheal aspirate);
  • Upper respiratory specimen (e.g., nasopharyngeal and oropharyngeal [NP/OP] swab)

For Further Guidance

MCDPH Webinars for Healthcare Professionals (Register for the webinars every Tuesday)


Documents from State and County Public Health

Online Resources for National, State, and Local Public Health

  • General information: MCDPH, ADHS, and CDC websites
  • Information for Healthcare Professionals:
    • CDC website
    • MCDPH guidance for evaluation of a patient with suspected COVID-19 infection (below)
  • Management of patients with confirmed coronavirus disease 2019: CDC website
  • Infection control:
    • Guidance from Arizona Department of Health (above)
    • CDC website
    • Attached example visual alert for posting at the entrance and strategic places in English and Spanish (see above)
  • Early epidemiology of cohort with COVID-19 in China: As described in NEJM
  • State Licensing: